CNBC
cnbc.com
did:plc:m7ks2xhfuku7errrtfjux2lg
Replimune to resubmit twice-rejected drug for approval after FDA shakeup https://cnb.cx/43n4pU1
2026-05-29T12:55:27.480Z
Enable JavaScript to use Bluesky.
Learn more about Bluesky at bsky.social and atproto.com.